Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity
Abstract Obesity is a recognized factor influencing immune function and infectious disease outcomes. Characterization of the influence of obesity on SARS-CoV-2 humoral vaccine immunogenicity is required to properly tailor vaccine type (mRNA, viral-vector, protein subunit vaccines) and dosing schedul...
Saved in:
| Main Authors: | Mathieu D’Souza, Alexa Keeshan, Christopher A. Gravel, Marc-André Langlois, Curtis L. Cooper |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | npj Vaccines |
| Online Access: | https://doi.org/10.1038/s41541-024-01022-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Repeated Variant Exposures on Cellular and Humoral Immunogenicity Induced by SARS-CoV-2 Vaccines
by: Leire Fernández-Ciriza, et al.
Published: (2024-12-01) -
Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection
by: Monrat Chulanetra, et al.
Published: (2024-11-01) -
Humoral and cellular response to SARS-CoV-2 mRNA vaccine in paediatric heart transplant recipients
by: Amanda Bermejo-Gómez, et al.
Published: (2025-01-01) -
Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica
by: Elisabeth Brouwer, et al.
Published: (2022-09-01) -
Design, Development and Immunogenicity Study of a Multi-Epitope Vaccine Prototype Against SARS-CoV-2
by: Mariyana Atanasova, et al.
Published: (2024-11-01)